Note

Recent Administrative Reforms of the Hatch-Waxman Act: Lower Prices Now in Exchange for Less Pharmaceutical Innovation Later?

Author: Douglas A. Robinson (Washington University School of Law)

Abstract

Keywords: Administrative law reform, Drugs -- Prices, Drugs -- Patents, Generic drugs, Pharmaceutical industry, United States. Food and Drug Administration, Drug Price Competition and Patent Term Restoration Act of 1984

How to Cite: Robinson, D. (2003) “Recent Administrative Reforms of the Hatch-Waxman Act: Lower Prices Now in Exchange for Less Pharmaceutical Innovation Later?”, Washington University Law Review. 81(3).